SKINVISIBLE, Inc. (SKVI) intrinsic value & 10-year financials

SKINVISIBLE, Inc. (SKVI) has no Graham intrinsic value right now because the formula needs positive earnings. Over the last 10 fiscal years revenue shrank 17.2% a year to $20.0K, with an average return on invested capital of 405.6%.

Graham intrinsic value
—
Share price (Oct 17, 2026)
$0.20
Market cap
$1.0M
Revenue (FY2025)
$20.0K
Revenue growth (10-yr CAGR)
-17.2%
ROIC (10-yr avg)
405.6%
Free cash flow (FY2025)
-$42.5K

SKVI 10-year financial history

Fiscal year Revenue Net income EPS (diluted) Free cash flow Operating margin ROIC
FY2025 $20.0K -$1.1M — -$42.5K -2481.6% —
FY2024 $20.0K -$41.0M -$0.11 -$79.1K -2947.9% —
FY2023 $20.0K -$39.9M -$0.52 -$86.5K -2451.9% —
FY2022 $279.3K -$37.0M -$0.27 $42.6K -85.4% —
FY2021 $663.4K -$35.8M -$0.24 $353.7K 28.3% —
FY2020 $152.6K -$34.7M -$0.32 $29.0K -166.2% —
FY2019 $43.2K -$33.3M — -$154.3K -1250.5% —
FY2018 $69.3K $158.3K — — -862.2% —
FY2017 $629.0K -$1.8M — — -57.9% —
FY2016 $108.9K -$2.1M — — -773.0% —

Source: annual 10-K filings on SEC EDGAR. Figures in USD.

Executive summary

SKINVISIBLE, INC. is facing top-line stagnation, with revenue contracting over the decade.

SKINVISIBLE, INC. 10-year average ROIC is N/A; capital efficiency cannot be assessed from the available history.

SKINVISIBLE, INC. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.

Benjamin Graham lens

Under Benjamin Graham's formula using SEC EDGAR fundamentals, SKINVISIBLE, INC. is modeled at -17.2% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $-0.12 per share.

SKVI stock: frequently asked questions

How fast has SKINVISIBLE, Inc. grown?

Revenue went from $108.9K in fiscal 2016 to $20.0K in fiscal 2025, a compound annual growth rate of -17.2%. Net income was -$1.1M in fiscal 2025.

Does SKINVISIBLE, Inc. generate free cash flow?

SKINVISIBLE, Inc. generated -$42.5K of free cash flow (operating cash flow minus capital expenditures) in fiscal 2025. Free cash flow was positive in 3 of the last 7 reported years.

What is SKVI's return on invested capital?

Average ROIC over the last 10 fiscal years was 405.6%, and average return on equity was 415.9%. Sustained ROIC above about 15% usually points to a durable competitive advantage.

Where does this SKVI data come from?

From SKINVISIBLE, Inc.'s annual 10-K filings on SEC EDGAR, most recently filed Aug 13, 2026. Prices are end-of-day snapshots; valuations are formula outputs, not investment advice.

Similar pharmaceutical preparations stocks